Concord Medical Services (NYSE:CCM) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Performance

NYSE:CCM opened at $4.94 on Wednesday. The business’s 50-day moving average price is $4.84 and its two-hundred day moving average price is $5.94. Concord Medical Services has a twelve month low of $3.82 and a twelve month high of $26.70. The company has a quick ratio of 0.46, a current ratio of 0.47 and a debt-to-equity ratio of 1.15.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.